Pharmaceutical preparations, except biologicals : 2001 by unknown
 Pharmaceutical Preparations,





Current data are released electronically on Internet system, and metabolic diseases for human use
for all individual surveys as they become avail- totaled $14.4 billion, a 47.5-percent increase 
able.  Use: http://www.census.gov/mcd/. from $9.8 billion in 2000; pharmaceutical pre-
Individual reports can be accessed by choosing parations acting on the central nervous system
"Current Industrial Reports (CIR)," clicking on and sense organs for human use totaled $19.7
"CIRs by Subsector;" then choose the survey of billion, a 6.6-percent increase from $18.5 billion
interest.  Follow the menu to view the PDF file in 2000; pharmaceutical preparations acting on
or to download the worksheet file (WK format) the cardiovascular system for human use totaled
to your personal computer. $9.7 billion, a 7.9-percent increase from $9.0
billion in 2000; pharmaceutical preparations 
These data are also available on Internet acting on the respiratory system for human use
through the U.S. Department of Commerce totaled $11.7 billion, a 14.5 percent increase 
and STAT-USA by subscription.  The Internet from $10.2 billion in 2000; pharmaceutical
address is:  www.stat-usa.gov/.  Follow the preparations acting on the digestive or genito-
prompts to register.  Also, you may call urinary system for human use totaled $12.7
202-482-1986 or 1-800-STAT-USA, for billion, a 25.9-percent increase from $10.0
further information. billion in 2000; pharmaceutical preparations
acting on the skin for human use totaled $2.7
SUMMARY OF FINDINGS billion, which is a 7.6-percent decrease from 
$2.9 billion in 2000; vitamin, nutrient, and
The total value of shipments for pharmaceutical hematinic preparations for human use totaled
preparations in the United States totaled $90.7 $6.1 billion, a 7.0-percent increase from $5.7
billion in 2001, a 14.4-percent increase from billion in 2000; pharmaceutical preparations
$79.3 billion in 2000.  The leading product affecting parasitic and ineffective diseases for
category was pharmaceutical preparations that human use amounted $11.2 billion, a 1.6-percent
act on the central nervous system and sense increase from $11.0 billion in 2000; and 
organs in humans, which increased 6.6 percent pharmaceutical preparations for veterinary use
to $19.7 billion in 2001, from $18.5 billion in amounted to $2.5 billion, a 19.2-percent increase
2000. from $2.1 billion in 2000.
The value of shipments for individual product For general CIR information, explanation of
categories in 2001 were:  pharmaceutical general terms and historical note, see the
preparations affecting neoplasm, endocrine appendix.
Address inquiries concerning these data to Primary Goods Industries Branch, Manufacturing and Construction Division (MCD), Washington, DC 20233-6900, 
or call Luis A. Blanco, 301-457-4643.
For mail or fax copies of this publication, please contact the Information Services Center, MCD, Washington, DC 20233-6900, or call 301-457-4673.
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Table 1.  Value of Product Class Shipments of Pharmaceutical Preparations, Except Biologicals:  1997 to 2001
[In thousands of dollars]     
Product
code Product description 2001 2000 1999 1998 1997
Pharmaceutical preparations...........................................................90,673,846 79,261,643 70,417,329 65,711,779 57,418,629
3254121000     Pharmaceutical preparations 
      affecting neoplasms, endocrine
      system, and metabolic diseases,
      for human use.................................................................................14,426,585 r/   9,783,996 7,987,700 7,633,235 5,465,948
3254124000     Pharmaceutical preparations 
      acting on the central nervous 
      system and sense organs, for
      human use....................................................................................19,736,685 r/ 18,508,356 14,881,433 13,604,818 11,708,007
3254127000     Pharmaceutical preparations 
      acting on the cardiovascular 
      system, for human use..................................................................9,700,082 8,992,634 9,601,073 9,368,031 8,799,338
325412A000     Pharmaceutical preparations 
      acting on the respiratory 
      system, for human use..................................................................11,653,306 10,179,464 8,154,675 6,724,706 5,641,256
325412D000     Pharmaceutical preparations 
      acting on the digestive or
      genito-urinary system,
      for human use..............................................................................12,651,508 10,046,469 8,741,429 9,501,593 9,482,082
325412G000     Pharmaceutical preparations
      acting on the skin, for human
      use...................................................................................................................................2,716,731 2,941,278 2,797,712 2,244,969 1,867,102
325412L000     Vitamin, nutrient, and 
      hematinic preparations, 
      for human use...................................................................................................................................6,071,505 r/   5,676,429 6,160,693 5,851,359 5,088,302
325412P000     Pharmaceutical preparations 
      affecting parasitic and
      ineffective diseases, for
      human use.....................................................................................11,218,510 11,036,891 9,778,226 8,780,375 7,794,882
325412T000     Pharmaceutical preparations
      for veterinary use........................................................................2,498,534 r/   2,096,126 2,314,388 2,002,693 1,571,712
      r/Revised by 5 percent or more from previously published data.
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325412 Pharmaceutical preparations
  (except biologicals)......................................................................................................................................................90,673,846 76,089,144 13,314,871 1,269,831 79,261,643 64,472,178 r/ 14,307,877 1,141,064
3254121000     Pharmaceutical preparations affecting
      neoplasms, endocrine system, and
      metabolic diseases, for human use.....................................................................................................................................14,426,585 14,239,521 44,032 a/  143,832 r/ 9,783,996 r/  9,613,766 12,625 157,605
        Hormones and synthetic substitutes:
            Corticoids:   
3254121011                 Systemic..............................................................................................344,451 (D) (D) (D) r/    331,581 (D) (D) (D)
3254121016                 Local and topical, including anti-
                  infective combinations...............................................................337,507 296,554 40,953 - 428,527 420,757 7,770 -
3254121021             Androgens............................................................................................(D) (D) - (D) (D) (D) - (D)
3254121026             Estrogens..................................................................................................................299,535 299,535 - - 244,075 244,075 - (D)
3254121031             Insulin and antidiabetic agents..................................................2,403,187 2,403,187 - (D) 2,090,790 2,090,790 - (D)
3254121036             ACTH (corticotropin)...............................................................................(D) (D) - - (D) (D) - -
3254121041             Oral contraceptive preparations...............................................................a/  122,698 a/  122,698 - - 115,893 115,893 - -
3254121046             Progestogens, excluding premenstrual   
              tension preparations (see code 
              325412D085).........................................................................................(D) (D) - (D) (D) (D) - (D)
3254121051             Sex hormone combinations, (except
             progestogen combinations).............................................................................................(D) (D) - - (D) (D) - -
3254121056             Thyroid and antithyroid preparations,
              including iodides...............................................................................................(D) (D) - - 21,577 (D) (D) -
3254121061             Anabolic agents..................................................................................(D) (D) - - (D) (D) (D) -
3254121066             Other hormone preparations..................................................................................(D) (D) (D) (D) (D) (D) (D) (D)
        Antineoplastic agents:
3254121071             Radioactive isotopes for internal use.........................................................................................(D) (D) - - 59,014 59,014 - -
3254121076             Specific antineoplastic agents...........................................................2,895,685 2,895,685 - (D) 2,098,510 2,098,510 - (D)
3254121081         Other pharmaceutical preparations
          affecting neoplasms, the endocrine   
          system, and metabolic diseases for   
          human use..............................................................................................................6,357,237 (D) (D) 108,219 r/ 4,107,536 (D) (D) 101,005
3254124     Pharmaceutical preparations acting on the
      central nervous system and the sense
      organs, for human use......................................................................................................19,736,685 a/16,959,321 2,534,403 242,961 18,508,356 16,073,284 2,211,990 223,082
3254124011         Parasympathomimetic cholinergic
          drugs.........................................................................................(D) (D) - (D) 17,113 17,113 - (D)
3254124014         Skeletal muscle relaxants......................................................................258,276 258,276 - (D) 212,703 212,703 - (D)
        Internal analgesics and antipyretics:
           Narcotic:
3254124017                Opium and derivatives..............................................................................572,487 572,487 - (D) r/    473,630 r/    473,630 - (D)
3254124021                Synthetic narcotics..................................................................................338,170 338,170 - (D) r/    334,229 r/    334,229 - (D)
           Nonnarcotic:
               Salicylates:
3254124024                   Aspirin (acetylsalicylic acid)............................................................................................293,962 (D) (D) (D) 275,647 (D) (D) (D)
3254124027                   Other salicylates, such as sodium
                    salicylate 2/...............................................................................................(D) (D) (D) (D) (D) (D) (D) (D)
3254124031                Aspirin combinations...................................................................................................183,056 (D) (D) - r/    137,522 (D) (D) -
3254124034                Acetaminophen and combinations...............................................................................492,108 a/    69,155 422,953 28,968 475,643 35,992 439,651 80,584
3254124037                Antiarthritics (nonhormonal)......................................................................................2,901,192 2,570,097 331,095 31,171 2,664,637 2,347,218 317,419 29,981
3254124041         Other internal analgesics and antipyretics,
          including effervescent types and
          suppositories 2/...............................................................................................338,237 (D) (D) (D) 214,435 (D) (D) (D)
3254124044         Anticonvulsants (except phenobarbital)......................................................749,477 749,477 - 6,865 592,685 592,685 - 5,731
        Psycotherapeutic agents:
3254124047            Antidepressants.................................................................................................................(D) (D) (D) (D) (D) (D) (D) (D)
           Tranquilizers:
3254124051               Phenothiazine derivatives.....................................................................................(D) (D) - (D) (D) (D) - -
3254124054               Other tranquilizers.........................................................................................................77,805 77,805 - - 81,798 81,798 - -
3254124057            Other psychotherapeutic agents...........................................................................1,446,471 1,446,471 - (D) 1,662,511 1,662,511 - (D)
        Central nervous system stimulants
          (respiratory and cerebral stimulants,
          including sympathomimetic agents
          employed mainly as CNS stimulants);
          excluding nondrug dietaries for weight 
          control):
3254124061             Amphetamines............................................................................................................(D) (D) - - (D) (D) - -
3254124064             Anorexiants (except amphetamines).................................................................................104,623 (D) (D) (D) 88,849 (D) (D) (D)
3254124067             Other CNS stimulants........................................................................................527,851 (D) (D) (D) r/    214,212 (D) (D) (D)
        Sedatives and hypnotics:
            Prescription:
3254124071                Barbiturates................................................................................33,152 33,152 (X) (D) r/      72,390 r/      72,390 (X) (D)
3254124074                Nonbarbiturates..................................................................................................(D) (D) (X) - (D) (D) (X) (D)
            Nonprescription:
3254124077                 Sleep inducers..................................................................................84,050 (X) 84,050 (D) 118,487 (X) 118,487 (D)
3254124081                 Calming agents.................................................................................................(D) (X) (D) - (D) (X) (D) -
        Anesthetics (except urinary tract
          anesthetics) and skin preparations
          used as antipruritics:
3254124084             Local and topical......................................................................................................................................289,836 (D) (D) (D) 298,017 (D) (D) (D)
3254124087             General.......................................................................................................(D) (D) (D) (D) (D) (D) (D) (D)
        Eye and ear preparations, excluding
          anti-infectives, corticoids and
          antibacterials and antiseptics:
3254124091             Mydriatics and miotics............................................................................................(D) (D) - - (D) (D) - -
3254124093             Contact lens solutions............................................................................................533,002 - 533,002 (D) 529,104 - 529,104 (D)
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3254124095             Other eye and ear preparations..................................................................654,036 (D) (D) - 485,496 (D) (D) -
3254124097         Other pharmaceutical preparations
          acting on the central nervous system
          and the sense organs for human use..........................................................................................................3,028,161 (D) (D) (D) r/  2,747,277 (D) (D) (D)
3254127     Pharmaceutical preparations acting on the
      cardiovascular system, for human use..........................................................................................9,700,082 (D) (D) (D) 8,992,634 (D) (D) (D)
3254127011         Anticoagulants.........................................................................................................733,724 (D) (D) (D) 626,471 (D) (D) (D)
3254127016         Hemostatics............................................................................................................(D) (D) - - (D) (D) - -
3254127021         Digitalis preparations.................................................................................................(D) (D) - (D) (D) (D) - (D)
        Hypotensives:
3254127026             Rauwolfia-alkaloid preparations...........................................................b/      6,086 b/      6,086 - - 9,283 9,283 - -
3254127031             Beta receptor blocking agents.........................................................................157,929 157,929 - - 142,831 142,831 - -
3254127036             Other hypotensives...................................................................................................372,135 372,135 - (D) 268,129 268,129 - (D)
        Vasodilators:
3254127041             Coronary.............................................................................................................673,525 673,525 - (D) 371,661 371,661 - (D)
3254127046             Peripheral...........................................................................................................46,392 46,392 - - 52,179 52,179 - -
3254127051             Antiarrythmics, such as propanolol
              and quinidine......................................................................................................214,939 214,939 - - 260,312 260,312 - -
3254127056             Calcium channel blockers such as
              sioptin, calan, procardia, cardizem,
              adalat..............................................................................................................................707,793 707,793 - (D) 695,044 695,044 - (D)
3254127061             Ace inhibitors, such as vasotec,
               capoten, prinivil, and zestril........................................................................................(D) (D) - - (D) (D) - -
3254127066         Other pharmaceutical preparation, acting
          on the cardiovascular system, including
          vasopressors, and antiheparin agents
          for, human use.....................................................................................3,405,960 (D) (D) (D) 3,471,472 (D) (D) (D)
325412A     Pharmaceutical preparations acting on the
      respiratory system, for human use...................................................................................................11,653,306 a/ 9,644,910 1,927,317 a/    81,079 10,179,464 7,320,010 2,782,459 76,995
325412A011        Antihistamines (except cold preparations
         and antiemetics)...........................................................................................................(D) (D) 282,238 (D) (D) (D) 276,031 (D)
325412A016        Bronchial dilators, including antiasthmatics......................................2,352,387 2,333,095 19,292 (D) r/  1,288,244 r/  1,263,672 24,572 (D)
       Cough and cold preparations (prescription):
           Cough preparations and expectorants
             (containing antitussive or other
             ingredients intended primarily to
             treat cough only):
325412A021                Narcotic...........................................................................................................134,257 134,257 (X) - 104,790 104,790 (X) -
325412A026                Nonnarcotic........................................................................................................79,930 79,930 (X) (D) 77,264 77,264 (X) -
          Cold preparations containing combinations
            of the following ingredients, (but not
            antitussive):  nasal decongestant, nasal   
            decongestant, antihistamine, analgesic,
            bioflavanoid, or anitbiotic:
325412A031               Nasal decongestants................................................................................................(D) (D) (X) - (D) (D) (X) (D)
325412A036               Antihistamine cold preparations................................................................................................(D) (D) (X) - (D) (D) (X) -
325412A041               Other prescription cold preparations...........................................................................20,849 20,849 (X) (D) 21,320 21,320 (X) (D)
325412A046           Cough and cold combinations   
            (prescription)...............................................................................................................141,421 141,421 (X) - 155,116 155,116 (X) -
          Cough and cold preparations (non-
            prescription):
             Decongestants:
325412A051                  Nasal sprays.......................................................................................................105,807 (X) 105,807 - 114,289 (X) 114,289 -
325412A056                  Nose drops........................................................................................................764 (X) 764 - 768 (X) 768 -
325412A061                  Other decongestants...............................................................................................153,178 (X) 153,178 (D) 189,740 (X) 189,740 -
325412A066              Cough syrups.........................................................................................................741,839 (X) 741,839 - 715,807 (X) 715,807 -
325412A071              Capsules and tablets.................................................................................................513,843 (X) 513,843 b/    25,353 1,351,358 (X) 1,351,358 24,085
325412A076              Lozenges.............................................................................................................18,151 (X) 18,151 - 14,032 (X) 14,032 -
325412A081              Topical preparations.................................................................................................(D) (X) (D) - (D) (X) (D) -
325412A086              Cough drops..........................................................................................................(D) (X) (D) - (D) (X) (D) -
325412A091              Other nonprescription cough and cold
               preparations..............................................................................................53,051 (X) 53,051 (D) 53,855 (X) 53,855 (D)
325412A094              Beta agonists such as proventil and
               ventolin.................................................................................................1,021,212 (D) (D) (D) 936,243 (D) (D) (D)
325412A097           Other pharmaceutical preparations
            acting on the respiratory system, for
            human use...............................................................................................................3,628,547 3,622,153 6,394 (D) r/  2,893,019 r/  2,887,233 5,786 (D)
325412D      Pharmaceutical preparations acting on the
       digestive or the genito-urinary systems,
       for human use.............................................................................................................12,651,508 11,137,449 1,379,959 134,100 10,046,469 8,680,376 r/   1,261,893 104,200
        Digestive system preparations: 
325412D011             Enzymes..............................................................................................................(D) (D) (D) (D) 388,519 (D) (D) (D)
325412D014             Antacids, including acid neutralizing
              products with coating functions, but
              excluding effervescent salicylate
              products classified as analgesics.................................................................577,114 413,896 535,718 (D) r/     539,679 11,712 r/      527,967 (D)
325412D017         Antidiarrheals.........................................................................................................536,567 (D) (D) (D) 384,564 (D) (D) (D)
        Laxatives:
325412D021             Irritants............................................................................................................78,195 (D) (D) (D) 81,907 (D) (D) (D)
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325412D024             Bulk producing.......................................................................................................(D) - (D) (D) (D) 5,670 (D) (D)
325412D027             Fecal softeners......................................................................................................58,095 (D) (D) (D) 38,467 (D) (D) (D)
325412D031             Emollients...........................................................................................................(D) - (D) (D) (D) - (D) (D)
325412D034             Saline...............................................................................................................(D) - (D) - (D) - (D) -
325412D037             Enema specialties....................................................................................................40,131 (D) (D) (D) 39,642 (D) (D) (D)
325412D041         Digestants.............................................................................................................(D) - (D) (D) (D) - (D) (D)
325412D044         Bile therapy preparations, including
          bile products, choleretics, and
          cholagogues....................................................................................................(D) (D) (D) (D) (D) (D) (D) -
325412D047         Antinauseants and motion sickness
          remedies (antiemetics), including
          antihistaminic antiemetic preparations...............................................................................(D) (D) (D) (D) (D) (D) (D) (D)
325412D051         Lipotropics and cholesterol reducers.........................................................................(D) (D) (D) (D) (D) (D) (D) (D)
325412D054         Diet aids containing local anesthetics
          such as benzocaine.............................................................................................................(D) (D) - (D) 7,056 (D) (D) (D)
        Antispasmodics and anticholinergics:
325412D057             Synthetics...........................................................................................................25,656 25,656 - - 21,413 21,413 - -
325412D061             Ataractic combinations..........................................................................................- - - - - - - -
325412D064             Belladonna and derivatives.............................................................................(D) (D) - (D) (D) (D) - (D)
325412D067             H2 blocking agents such as zantac,
              tagemet, carafate and pepcid.................................................................................................1,654,668 1,592,649 62,019 - 1,660,555 1,635,606 24,949 -
325412D071             Other antispasmodics and anti-
              cholinergics.........................................................................................................32,814 (D) (D) - 25,309 (D) (D) -
325412D074         Other digestive system preparations,
          including emetics............................................................................................(D) (D) (D) (D) 70,499 (D) (D) (D)
        Genito-urinary preparations:   
325412D077             Urinary antibacterials and antiseptics.....................................................215,729 214,263 1,466 (D) 162,820 161,637 r/          1,183 (D)
            Diuretics, excluding aminophylline,
              xanthine, and rauwolfia-diuretic
              combinations (see cardiovascular
              preparations):
325412D081                 Thiazides and related agents............................................................................................68,213 68,213 - - r/      44,856 r/      44,856 - -
325412D084                 Other diuretics....................................................................................................122,089 (D) (D) (D) 118,001 (D) (D) (D)
325412D087             Oxytocics............................................................................................................55,072 55,072 - - r/      49,606 r/      49,606 - -
325412D091             Contraceptive agents (except oral
              contraceptives; i.e., aerosols, jels,
              sponges, and creams)...............................................................................................................(D) (D) (D) - (D) (D) (D) -
325412D093             Premenstrual tension preparations.................................................................................................(D) - (D) - (D) - (D) -
325412D095             Vaginal cleaners........................................................................................................................(D) (D) (D) - (D) (D) (D) -
325412D097         Other pharmaceutical preparations acting
          on the genito-urinary system, including
          urinary tract anesthetics, for human use................................................1,522,242 1,452,406 65,613 4,223 r/ 1,129,250 r/ 1,075,183 r/        49,402 4,665
325412G     Pharmaceutical preparations acting on the
      skin, for human use...............................................................................................................2,716,731 (D) (D) (D) 2,941,278 (D) (D) (D)
        Dermatological preparations:
325412G011             Emollients and protectives, including
              burn remedies and ointment bases...........................................................................546,939 (D) (D) (D) 659,597 (D) (D) (D)
325412G016             Antipruritics and local anesthetic       
               skin preparations........................................................................................................(D) (D) (D) (D) 179,951 (D) (D) (D)
325412G021             Coal tar, sulfur and resorcinol
               preparations.........................................................................a/    21,410 (D) (D) - r/      22,056 (D) (D) -
325412G026              Antiacne preparations................................................................................................479,664 (D) (D) (D) r/    446,348 (D) (D) (D)
325412G031              Antidandruff and antiseborrheic
               preparations (except dandruff
               shampoos)............................................................................................26,692 (D) (D) - 18,453 (D) (D) -
325412G036             Other dermatological preparations.....................................................................................297,691 (D) (D) (D) 333,552 (D) (D) (D)
325412G041         Hemorrhoidal preparations..............................................................................................104,899 (D) (D) - 117,172 (D) (D) -
        External analgesics and counterirritants:
325412G046             Ointments, jellies, pastes, creams,
              cerates, and salves..........................................................................................................363,223 (D) (D) - 405,333 (D) (D) (D)
325412G051             Liquid, excluding rubbing alcohol, but
              including liniments..........................................................................................................23,995 - 23,995 - 23,145 - 23,145 -
325412G056             Rubbing alcohol......................................................................................................a/    31,509 (D) (D) - 25,441 (D) (D) -
325412G061             Other external analgesics and counter-
              irritants....................................................................................................................................(D) (D) (D) (D) 88,388 (D) (D) (D)
325412G066         Other pharmaceutical preparations acting
          on the skin, for human use.........................................................................................................604,744 (D) (D) - r/    621,842 r/    573,090 48,752 -
325412L     Vitamin, nutrient, and hematinic preparations,
      for human use...............................................................................................................6,071,505 2,001,883 3,730,324 b/  339,298 r/ 5,676,429 r/ 1,506,670 3,873,269 296,490
        Vitamins:
325412L011            Multivitamins, plain and with minerals,
              (except B complex vitamins and fish
              liver oils)..........................................................................................................1,813,837 27,806 1,786,031 a/    41,129 r/ 1,909,922 12,542 r/   1,897,380 41,594
325412L016            Pediatric vitamin preparations (drops,
             suspensions and chewable tablets)..................................................................b/  131,351 (D) (D) 806 127,486 (D) (D) 724
325412L021            Prenatal vitamin preparations........................................................................................51,770 (D) (D) (D) 40,923 (D) (D) (D)
325412L026            B complex preparations...............................................................................................144,775 4,315 140,460 a/      5,777 154,280 4,122 150,158 5,303
325412L031            Fluoride preparations................................................................................................3,456 (D) (D) - 3,703 (D) (D) -
325412L036            All other vitamin preparations.......................................................................................a/  851,808 (D) (D) (D) 721,110 (D) (D) (D)
325412L041         Fish liver oils (cod, etc.)............................................................................................43,912 (D) (D) (D) 40,063 (D) (D) (D)
325412L046         Nutrients, excluding therapeutic dietary
          foods and infant formulas...................................................................................................318,578 32,070 286,508 - r/    352,606 24,717 r/      327,889 (D)
325412L051         Tonics and alteratives.................................................................................................a/    10,049 (D) (D) - r/      14,216 (D) (D) -
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        Hematinics:
            With B12:
325412L056                 Oral...............................................................................................................23,203 21,885 1,318 - 26,991 25,169 1,822 281
325412L061                 Parenteral.........................................................................................................(D) (D) - - (D) (D) - -
            Other hematinics:
325412L066                 Oral...............................................................................................................27,231 (D) (D) (D) 18,989 (D) (D) (D)
325412L071                 Parenteral.........................................................................................................(D) (D) - - (D) (D) - -
325412L076         Hospital solutions, including dextran,
          etc., but excluding biologicals such as
          blood plasma..................................................................................................(D) (D) (D) - (D) (D) (D) -
325412L081         Other vitamin, nutrient, and hematinic
          preparations, for human use...........................................................................................975,004 (D) (D) 64,409 r/    940,458 r/    332,966 r/      607,492 39,781
325412P     Pharmaceutical preparations affecting
      parasitic and infective diseases, for
      human use..............................................................................................................................11,218,510 10,077,407 1,095,376 a/    45,727 11,036,891 9,586,357 1,382,249 68,285
        Anti-infective agents, excluding cortcoid   
          anti-infective combinations (see product 
          code 3254121015):   
325412P011             Amebicides and trichomonicides.......................................................................................30,420 30,420 - - 11,686 11,686 - -
325412P014             Anthelmintics........................................................................................................716 (D) (D) - 6,348 (D) (D) -
            Systemic antibiotic preparations:   
                Broad and medium spectrum (single
                  or in combinations with other 
                  antibiotics):
325412P017                     Tetracyclines, including chlortetracy
                      cline and congeners...................................................................................................89,267 89,267 - - 102,261 102,261 - -
325412P021                     Cephalosporins, such as cefaman-
                      dolenafate and cephalexin...........................................................................................1,140,742 1,140,742 - - r/  1,632,102 r/ 1,632,102 - (D)
325412P024                     Erythromycins, such as erythromycin
                      ethylsuccinate and erythromycin
                      stearate......................................................................................................52,722 52,722 - - 56,603 56,603 - -
                    Penicillins (single):
                        Semisynthetic penicillins, such as
                          amoxicillins, and ampicillin:
325412P027                             Injectable...................................................................................................(D) (D) - - (D) (D) - -
325412P031                             Other forms..................................................................................................(D) (D) - - (D) (D) - -
                        Other penicillins (except semi-
                          synthetic) such as penicillin V
                          and penicillin G:
325412P034                             Injectable...................................................................................................(D) (D) - - (D) (D) - -
325412P037                             Other forms..................................................................................................(D) (D) - - (D) (D) - -
325412P041                    Other broad and medium spectrum
                     antibiotics (except sulfa-antibiotic
                     combinations)..........................................................................1,106,969 (D) (D) - 975,743 (D) (D) -
325412P044                Antibiotics in combination with
                 sulfonamides........................................................................................................(D) (D) - - (D) (D) - -
325412P047                Other systemic antibiotic preparations,
                 including narrow-spectrum antibiotics
                 and streptomycins.........................................................................................................................102,152 102,152 - (D) 96,285 96,285 - (D)
325412P051            Topical antibiotic preparations.......................................................................................................................191,615 (D) (D) (D) 118,075 (D) (D) (D)
           Tuberculostatic agents:
325412P054                Isoniazid (isonicotinic acid hydrazide)
                preparations.........................................................................................................................3,446 3,446 - - 4,753 4,753 - -
325412P057                Other antituberculars...............................................................................................(D) (D) - - 31,389 31,389 - -
325412P061             Antimalarials (plasmodicides).......................................................................................43,308 (D) (D) - 30,396 (D) (D) -
325412P064             Sulfonamides (except antibiotic
              sulfonamide combinations)....................................................................................................................27,856 27,856 - - 60,523 60,523 - -
325412P067             Antifungal preparations..............................................................................................748,866 (D) (D) - 697,926 (D) (D) -
325412P071             Antivirals, systemic, such as zovirax,
              and retrovir................................................................................................2,908,817 (D) (D) (D) 2,836,360 (D) (D) (D)
325412P074             Other anti-infective agents..........................................................................................(D) 59,565 (D) (D) (D) 79,262 (D) (D)
        Antibacterials and antiseptics:
325412P077             General...............................................................................................................382,538 (D) (D) 5,526 130,451 (D) (D) (D)
325412P081             Mouth and throat  preparations.......................................................................................(D) 4,234 (D) (D) (D) 9,670 (D) -
325412P084         Other pharmaceutical preparations
          affecting parasitic and infective  
          diseases, for human use.................................................................................380,366 (D) (D) - 902,485 (D) (D) -
325412T     Pharmaceutical preparations for veterinary
      use...................................................................................................................................2,498,534 1,312,189 1,103,744 82,601 r/  2,096,126 r/    999,688 1,057,309 39,129
325412T011         Anesthetics............................................................................................................(D) (D) (D) - (D) (D) (D) -
325412T016         Anthelmintics..........................................................................................................297,805 231,926 65,879 (D) r/    243,799 r/    189,137 r/        54,662 (D)
        Antibiotics:
325412T021             Tetracyclines........................................................................................................27,182 (D) (D) (D) 32,469 (D) (D) (D)
325412T026             Penicillins..........................................................................................................39,888 (D) (D) (D) 47,205 (D) (D) (D)
325412T031             Other antibiotics....................................................................................................378,699 251,867 126,832 (D) 246,302 111,754 134,548 (D)
325412T036         Antiseptics, wound dressings and fungicides.............................................50,341 21,330 29,011 (D) 35,912 940 34,972 (D)
325412T041         Hematinics 3/.............................................................................................................(D) (D) (D) (D) (D) (D) (D) (D)
325412T046         Hemostatics 3/............................................................................................................8,447 (D) (D) - 7,487 (D) (D) -
        Hormones:
325412T051             Insulin preparations.................................................................................................- - - - - - - -
325412T056             ACTH (corticotropin) preparations....................................................................................(D) (D) (D) - (D) (D) (D) -
325412T061             Other hormone preparations...........................................................................................(D) - (D) - 90,191 (D) (D) -
325412T066         Intravenous solutions and electrolytes................................................................................(D) - (D) - 10,805 (D) (D) -
325412T071         Nitrofurans............................................................................................................(D) - (D) (D) (D) - (D) (D)
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325412T076         Nutrients and tonics...................................................................................................(D) (D) 996 (D) (D) (D) 5,434 (D)
325412T081         Parasiticides, external................................................................................................201,060 (D) (D) (D) r/    233,212 (D) (D) (D)
325412T086         Sulfonamides...........................................................................................................10,922 (D) (D) - 11,523 (D) (D) (D)
325412T091         Tranquilizers and ataractics...........................................................................................23,548 (D) (D) - 22,277 (D) (D) -
325412T094         Vitamins and minerals..................................................................................................84,779 3,529 81,250 (D) 105,592 3,769 101,823 (D)
325412T097         Other pharmaceutical preparations for
          veterinary use..................................................................................................1,083,017 567,378 515,639 (D) 925,926 527,425 398,501 2,446
      - Represents zero.      D  Withheld to avoid disclosing data for individual companies.      r/Revised by 5 percent or more from previously published data.
X  Not applicable.
      1/Data for "Bulk shipments" are excluded from all horizontal ten-digit product detail totals; however, these data are included in all seven-digit product code and 
six-digit industry level totals.  Since bulk shipments are typically reported by a small number of producers, and often must be suppressed, inclusion of bulk
shipments in all horizontal totals would require the suppression of additional detail.
      2/Product code 3254124027 is combined with product code 3254124041 to avoid disclosing data for individual companies.
      3/Product code 325412T041 is combined with product code 325412T046 to avoid disclosing data for individual companies.
 
      Note:  Percent of estimation of each item is indicated as follows:  a/10 to 25 percent of this item is estimated.     b/26 to 50 percent of this item is estimated.
c/Over 50 percent of this item is estimated.




Product Product description shipments Exports of exports Imports for Apparent imports
code (value domestic to manu- consump- consump- to apparent
f.o.b. merchan- facturers' tion 2/ tion 3/ consump-
plant) dise 1/ shipments (value) (value) tion
 
2001  
Pharmaceutical preparations.............................................................................................................90,673,846 6,283,386 6.9 8,898,283 93,288,743 9.5
3254121000     Pharmaceutical preparations affecting neoplasms, endocrine
      system, and metabolic diseases, for human use..................................................................................................................14,426,585 1,419,234 9 8 2,173,270 15,180,621 14.3
3254124000     Pharmaceutical preparations acting on the central nervous
      system and sense organs, for human use.............................................................................................................19,736,685 1,529,078 7.7 1,328,285 19,535,892 6.8
3254127000     Pharmaceutical preparations acting on the cardiovascular  
      system, for human use.........................................................................................................................9,700,082 484,159 5.0 1,750,629 10,966,552 16.0
325412A000     Pharmaceutical preparations acting on the respiratory  
      system, for human use.............................................................................................................................11,653,306 267,312 2.3 574,629 11,960,623 4.8
325412D000     Pharmaceutical preparations acting on the digestive or  
      genito-urinary system, for human use.................................................................................................................12,651,508 522,490 4.1 1,441,006 13,570,024 10.6
325412G000     Pharmaceutical preparations acting on the skin, for human
      use.......................................................................................................................................................................2,716,731 59,410 2.2 82,579 2,739,900 3.0
325412L000     Vitamin, nutrient, and hematinic preparations, for human
      use...................................................................................................................................................................6,071,505 291,669 4.8 38,007 5,817,843 0.7
325412P000     Pharmaceutical preparations affecting parasitic and  
      infective diseases, for human use......................................................................................................................................11,218,510 1,514,560 13 5 1,104,814 10,808,764 10.2
325412T000     Pharmaceutical preparations for veterinary use............................................................................................................2,498,534 195,474 7 8 405,064 2,708,124 15.0
2000
Pharmaceutical preparations...........................................................................................................................................79,261,643 4,593,727 5.8 5,945,812 80,613,728 7.4
3254121000     Pharmaceutical preparations affecting neoplasms, endocrine
      system, and metabolic diseases, for human use.................................................................................................................9,783,996 1,128,432 11 5 1,632,933 10,288,497 15.9
3254124000     Pharmaceutical preparations acting on the central nervous
      system and sense organs, for human use..............................................................................................................18,508,356 681,674 3.7 757,262 18,583,944 4.1
3254127000     Pharmaceutical preparations acting on the cardiovascular  
      system, for human use.........................................................................................................................8,992,634 599,977 6.7 593,004 8,985,661 6.6
325412A000     Pharmaceutical preparations acting on the respiratory  
      system, for human use.............................................................................................................................10,179,464 225,294 2.2 139,452 10,093,622 1.4
325412D000     Pharmaceutical preparations acting on the digestive or  
      genito-urinary system, for human use.................................................................................................................10,046,469 408,809 4.1 901,677 10,539,337 8.6
325412G000     Pharmaceutical preparations acting on the skin, for human
      use..............................................................................................................................................................................2,941,278 63,861 2.2 145,029 3,022,446 4.8
325412L000     Vitamin, nutrient, and hematinic preparations, for human
      use...........................................................................................................................................................5,676,429 170,848 3.0 50,970 5,556,551 0.9
325412P000     Pharmaceutical preparations affecting parasitic and  
      infective diseases, for human use.....................................................................................................................................11,036,891 1,106,799 10 0 1,373,272 11,303,364 12.1
325412T000     Pharmaceutical preparations for veterinary use............................................................................................................2,096,126 208,033 9 9 352,214 2,240,307 15.7
      1/Source:  Census Bureau report EM 545, U.S. Exports.
      2/Source:  Census Bureau report IM 145, U.S. Imports for Consumption.
      3/Apparent consumption represents new domestic supply and is derived by substracting exports from the total of manufacturers' 
shipments plus imports.
Table 4.  Comparison of North American Industry Classification System (NAICS)-Based Product Codes with
                Schedule B Export Codes, and HTSUSA Import Codes:  2001
Product   
code Product description Export code 1/ Import code 2/
3254121000 Pharmaceutical preparations affecting
  neoplasms, endocrine system, and
  metabolic disease.................................................................................................3003 31 0000, 3003 39.0000, 3003.31.0000, 3003.39.1000,
3003.40.0000, 3004.31.0000, 3003.39.5000, 3003.40.0000,
3004.32.0000, 3004.39.0050, 3004.31.0000, 3004.32.0000,
3004.90.9015 3004.39.0050, 3004.90.9015
3254124000 Pharmaceutical preparations acting on
  central nervous system and sense
  organs...........................................................................................................................3004.40 0020, 3004 40.0030, 3004.40.0020, 3004.40.0030,
3004.40.0040, 3004.90.9025, 3004.40.0040, 3004.90.9030,
3004.90.9030, 3004.90.9035, 3004.90.9035, 3004.90.9040
3004.90.9040
3254127000 Pharmaceutical preparations acting on 
  cardiovascular system...............................................................................................................3004.40 0010, 3004.90 9020 3004.40.0010, 3004.90.9020
325412A000 Pharmaceutical preparations acting on
  respiratory system......................................................................................................3004.40 0060, 3004 90.9075, 3004.40.0060, 3004.90.9075,
3004.90.9080, 3004.90.9085 3004.90.9080, 3004.90.9085
325412D000 Pharmaceutical preparations acting on
  digestive or genitro-urinary system............................................................................3004 90 9050, 3004 90.9055, 3004.90.9050, 3004.90.9055,
3004.90.9060, 3004.90.9065, 3004.90.9060, 3004.90.9065,
3004.90.9070, 3006.60.0000 3004.90.9070, 3006.60.0000
325412G000 Pharmaceutical preparations acting on
  skin........................................................................................................................3004 40.0050, 3004.90.9045 3004.40.0050, 3004.90.9045
325412L000 Vitamin, nutrient and hematinic
  preparations...........................................................................................................3004 50.4500, 3004 50 5010, 3004.50.1000, 3004.50.2000,
3004.50.5020, 3004.50.5030, 3004.50.3000, 3004.50.4000,
3004.50.5040 3004.50.5010, 3004.50.5020,
3004.50.5030, 3004.50.5040
325412P000 Pharmaceutical preparations affecting
  parasitic and infective disease...........................................................................3003.10 0000, 3003 20.0000, 3003.10.0000, 3003.20.0000,
3004.10.1020, 3004.10.1045, 3004.10.1020, 3004.10.1045,
3004.10.5045, 3004.10.5060, 3004.10.5045, 3004.10.5060,
3004.20.0020, 3004.20.0030, 3004.20.0020, 3004.20.0030,
3004.20.0060, 3004.90.1000, 3004.20.0060, 3004.90.1000,
3004.90.9005, 3004.90.9010 3004.90.9005, 3004.90.9010
325412T000 Pharmaceutical preparations for
  veterinary use......................................................................................................3004.10 1010, 3004 10.5010, 3004.10.1010, 3004.10.5010,
3004.20.0010, 3004.39.0010, 3004.20.0010, 3004.39.0010,
3004.40.0005, 3004.50.5005, 3004.40.0005, 3004.50.5005,
3004.90.9003 3004.90.9003
      1/Source:  2001 edition, Harmonized System-based Schedule B, Statistical Classification of Domestic and Foreign
Commodities Exported from the United States.    
      2/Source:  Harmonized tariff Schedule of the United States, Annotated (2001).
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Appendix.  
General CIR Survey Information, Explanation of General Terms
and Historical Note
GENERAL
The CIR program has been providing monthly,
quarterly, and annual measures of industrial activity for
many years. Since 1904, with its cotton and fats and oils
surveys, the CIR program has formed an essential part
of an integrated statistical system involving the quin-
quennial economic census, manufacturing sector, and
the annual survey of manufactures. The CIR surveys,
however, provide current statistics at a more detailed
product level than either of the other two statistical
programs.
The primary objective of the CIR program is to
produce timely, accurate data on production and
shipments of selected products. The data are used to
satisfy economic policy needs and for market analysis,
forecasting, and decision making in the private sector.
The product-level data generated by these surveys are
used extensively by individual firms, trade associations,
and market analysts in planning or recommending
marketing and legislative strategies, particularly if their
industry is significantly affected by foreign trade.
Although production and shipments information are the
two most common data items collected, the CIR
program collects other measures also such as
inventories, orders, and consumption. These surveys
measure manufacturing activity in important commodity
areas such as textiles and apparel, chemicals, primary
metals, computer and electronic components, industrial
equipment, aerospace equipment, and consumer
goods.
The CIR program uses a unified data collection,
processing, and publication system. The U.S. Census
Bureau updates the survey panels for most reports
annually and reconciles the estimates to the results of
the broader-based annual survey of manufactures and
the economic census, manufacturing sector. The manu-
facturing sector provides a complete list of all
producers of the products covered by the CIR program
and serves as the primary source for CIR sampling.
Where a small number of producers exist, CIR surveys
cover all known producers of a product. However, when
the number of producers is too large, cutoff and
random sampling techniques are used. Surveys are
continually reviewed and modified to provide the most
up-to-date information on products produced. The CIR
program includes a group of mandatory and voluntary
surveys.  Typically the monthly and quarterly surveys are
conducted on a voluntary basis. Those companies that
choose not to respond to the voluntary surveys are
required to submit a mandatory annual counterpart
corresponding to the more frequent survey.
NORTH AMERICAN INDUSTRY CLASSIFICATION
SYSTEM (NAICS), 1997 
The adoption of the North American Industry
Classification System (NAICS) in the 1997 Economic
Census has had a major impact on the comparability of
current and historic data. Approximately half of the
industries in the manufacturing sector of NAICS do not
have comparable industries in the Standard Industrial
Classification (SIC) system that was used in the past.
While most of the change affecting the
manufacturing sector was change within the sector,
some industries left manufacturing and others came into
manufacturing. Prominent among those that left
manufacturing are logging and portions of publishing.
Prominent among the industries that came into the
manufacturing sector are bakeries, candy stores where
candy is made on the premises, custom tailors, makers
of custom draperies, and tire retreading. The net effect
of the classification changes are such that if the 1997
value of shipments data for all manufacturers were
tabulated on an SIC basis, it would be approximately 3
percent higher.







48-49 Transportation and Warehousing
51 Information
52 Finance and Insurance
53 Real Estate and Rental and Leasing
54 Professional, Scientific, and Technical Services
55 Management of Companies and Enterprises
56 Administrative and Support and Waste Management
and Remediation Services
61 Educational Services
62 Health Care and Social Assistance
71 Arts, Entertainment, and Recreation
72 Accommodation and Food Services
81 Other Services (except Public Administration)
(Not listed above are the Agriculture, Forestry,
Fishing, and Hunting sector (NAICS 11), partially covered
by the census of agriculture conducted by the U.S.
Department of Agriculture, and the Public
Administration sector (NAICS 92), covered by the census
of governments conducted by the Census Bureau.)
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The 20 NAICS sectors are subdivided into 96
subsectors (three-digit codes), 313 industry groups
(four-digit codes), and, as implemented in the United
States, 1170 industries (five- and six-digit codes).
FUNDING
The Census Bureau funds most of the surveys.
However, a number of surveys are paid for either fully
or partially by other Federal Government agencies or
private trade associations. A few surveys are mandated,
but all are authorized by Title 13 of the United States
Code.
RELIABILITY OF DATA
Survey error may result from several sources
including the inability to obtain information about all
cases in the survey, response errors, definitional
difficulties, differences in the interpretation of
questions, mistakes in recording or coding the reported
data, and other errors of collection, response,
coverage, and estimation. These nonsampling errors
also occur in complete censuses. Although no direct
measurement of the biases due to these nonsampling
errors has been obtained, precautionary steps were
taken in all phases of the collection, processing, and
tabulation of the data in an effort to minimize their
influence.
A major source of bias in the published estimates is
the imputing of data for nonrespondents, for late
reporters, and for data that fail logic edits. Missing
figures are imputed based on period-to-period
movements shown by reporting firms. A figure is
considered to be an impute if the value was not directly
reported on the questionnaire, directly derived from
other reported items, directly available from
supplemental sources, or obtained from the respondent
during the analytical review phase. Imputation generally
is limited to a maximum of 10 percent for any one data
cell. Figures with imputation rates greater than 10
percent are suppressed or footnoted. The imputation
rate is not an explicit indicator of the potential error in
published figures due to nonresponse, because the
actual yearly movements for nonrespondents may or
may not closely agree with the imputed movements.
The range of difference between the actual and
imputed figures is assumed to be small. The degree of
uncertainty regarding the accuracy of the published
data increases as the percentage of imputation
increases. Figures with imputation rates above 10
percent should be used with caution.
DATA REVISIONS
Statistics for previous years may be revised as the
result of corrected figures from respondents, late
reports for which imputations were originally made, or
other corrections. Data that have been revised by more
than 5 percent from previously published data are
indicated by footnotes.
DISCLOSURE
The Census Bureau collects the CIR data under the
authority of Title 13, United States Code, which
specifies that the information can only be used for
statistical purposes and cannot be published or released
in any manner that would identify a person, household,
or establishment.  "D" indicates that data in the cell have
been suppressed to avoid disclosure of information
pertaining to individual companies.
EXPLANATION OF GENERAL TERMS
Capacity. The maximum quantity of a product that can
be produced in a plant in 1 day if operating for 24
hours. Includes the capacity of idle plants until the plant
is reported to be destroyed, dismantled, or abandoned.
Consumption.  Materials used in producing or
processing a product or otherwise removing the
product from the inventory.
Exports.  Includes all types of products shipped to
foreign countries, or to agents or exporters for
reshipment to foreign countries.
Gross shipments. The quantity or value of physical
shipments from domestic establishments of all products
sold, transferred to other establishments of the same
company, or shipped on consignment, whether for
domestic or export sale or use. Shipments of products
purchased for resale are omitted. Shipments of
products made under toll arrangements are included.
Interplant transfers.  Shipments to other domestic
plants within a company for further assembly,
fabrication, or manufacture.
Inventories.  The quantity or value of finished goods,
work in progress, and materials on hand.
Machinery in place. The number of machines of a
particular type in place as of a particular date whether
the machinery was used for production, prototype, or
sampling, or was idle. Machinery in place includes all
machinery set up in operating positions.
Net receipts.  Derived by subtracting the materials held
at the end of the previous month from the sum of
materials used during the current month.
Production.  The total volume of products produced,
including: products sold; products transferred or added
to inventory after adjustments for breakage, shrinkage,
and obsolescence, plus any other inventory adjustment;
and products that undergo further manufacture at the
same establishment.  
Quantities produced and consumed. Quantities of
each type of product produced by a company for
internal consumption within that same company.
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Quantity and value of new orders.  The sales value
of orders received during the current reporting period
for products and services to be delivered immediately
or at some future date. Also represents the net sales
value of contract change documents that increase or
decrease the sales value of the orders to which they are 
related, when the parties concerned are in substantial
agreement as to the amount involved.  Included as
orders are only those that are supported by binding
legal documents such as signed contracts or letter
contracts.
Quantity and value of shipments.  The figures on
quantity and value of shipments represent physical
shipments of all products sold, transferred to other
establishments of the same company, or shipped on
consignment, whether for domestic or export sale. The
value represents the net sales price, f.o.b. plant, to the
customer or branch to which the products are shipped,
net of discounts, allowances, freight charges, and
returns. Shipments to a company's own branches are
assigned the same value as comparable appropriate
allocation of company overhead and profit. Products
bought and resold without further manufacture are
excluded.
Stocks. Total quantity of ending finished inventory.
Unfilled orders (backlog). Calculated by adding net
new orders and subtracting net sales from the backlog
at the end of the preceding year.
HISTORICAL NOTE
Data on pharmaceutical preparations, except
biologicals, have been collected by the Census Bureau
since 1962.  Historical data may be obtained from
Current Industrial Reports available at your local Federal
Depository Library.
